Carboprost tromethamine

An internal standard for the quantification of latanoprost by GC- or LC-mass spectrometry (MS).

1-Acetyl-2,2,5,5-tetramethyl-3-pyrroline-3-carboxylic Acid N-Hydroxysuccinimide Ester.

GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&amp:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is

GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&amp:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is

GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&amp:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is

GSK-3β Inhibitor VII is a phenyl α-bromomethyl ketone compound which acts as a cell-permeable, and non-ATP competitive inhibitor of glycogen synthase kinases (GSK-3&amp:beta): (IC = 0.5 μM). This compound acts as an alkylating agent that is

2-Acetylamino-3-[4-(2-acetylamino-2-carboxy-ethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid (2-AAPA) can block reductase systems, thereby modulating peroxiredoxin oxidation and mitochondrial function in A172 glioblastoma

2-Acetylamino-3-[4-(2-acetylamino-2-carboxy-ethylsulfanylthiocarbonylamino)phenylthiocarbamoylsulfanyl]propionic acid (2-AAPA) can block reductase systems, thereby modulating peroxiredoxin oxidation and mitochondrial function in A172 glioblastoma

2-Bromo-1-(tetrahydro-2H-pyran-4-yl)ethanone.

2-Bromo-1-(tetrahydro-2H-pyran-4-yl)ethanone.

2-Bromo-1-(tetrahydro-2H-pyran-4-yl)ethanone.

3-Amino-1H-pyrazole-4-carboxamide.